QQQ   293.72 (+0.12%)
AAPL   148.31 (+0.19%)
MSFT   254.69 (-0.18%)
META   120.44 (+1.98%)
GOOGL   100.99 (+0.00%)
AMZN   95.50 (-1.08%)
TSLA   194.70 (+0.00%)
NVDA   171.35 (+1.25%)
NIO   12.09 (-5.40%)
BABA   85.94 (-1.85%)
AMD   77.48 (-0.19%)
T   19.19 (-0.47%)
MU   55.49 (-3.75%)
CGC   3.93 (+8.56%)
F   14.08 (+1.29%)
GE   85.26 (-0.83%)
DIS   98.59 (+0.74%)
AMC   8.17 (+13.00%)
PYPL   78.53 (+0.15%)
PFE   51.08 (+1.90%)
NFLX   316.95 (+3.74%)
QQQ   293.72 (+0.12%)
AAPL   148.31 (+0.19%)
MSFT   254.69 (-0.18%)
META   120.44 (+1.98%)
GOOGL   100.99 (+0.00%)
AMZN   95.50 (-1.08%)
TSLA   194.70 (+0.00%)
NVDA   171.35 (+1.25%)
NIO   12.09 (-5.40%)
BABA   85.94 (-1.85%)
AMD   77.48 (-0.19%)
T   19.19 (-0.47%)
MU   55.49 (-3.75%)
CGC   3.93 (+8.56%)
F   14.08 (+1.29%)
GE   85.26 (-0.83%)
DIS   98.59 (+0.74%)
AMC   8.17 (+13.00%)
PYPL   78.53 (+0.15%)
PFE   51.08 (+1.90%)
NFLX   316.95 (+3.74%)
QQQ   293.72 (+0.12%)
AAPL   148.31 (+0.19%)
MSFT   254.69 (-0.18%)
META   120.44 (+1.98%)
GOOGL   100.99 (+0.00%)
AMZN   95.50 (-1.08%)
TSLA   194.70 (+0.00%)
NVDA   171.35 (+1.25%)
NIO   12.09 (-5.40%)
BABA   85.94 (-1.85%)
AMD   77.48 (-0.19%)
T   19.19 (-0.47%)
MU   55.49 (-3.75%)
CGC   3.93 (+8.56%)
F   14.08 (+1.29%)
GE   85.26 (-0.83%)
DIS   98.59 (+0.74%)
AMC   8.17 (+13.00%)
PYPL   78.53 (+0.15%)
PFE   51.08 (+1.90%)
NFLX   316.95 (+3.74%)
QQQ   293.72 (+0.12%)
AAPL   148.31 (+0.19%)
MSFT   254.69 (-0.18%)
META   120.44 (+1.98%)
GOOGL   100.99 (+0.00%)
AMZN   95.50 (-1.08%)
TSLA   194.70 (+0.00%)
NVDA   171.35 (+1.25%)
NIO   12.09 (-5.40%)
BABA   85.94 (-1.85%)
AMD   77.48 (-0.19%)
T   19.19 (-0.47%)
MU   55.49 (-3.75%)
CGC   3.93 (+8.56%)
F   14.08 (+1.29%)
GE   85.26 (-0.83%)
DIS   98.59 (+0.74%)
AMC   8.17 (+13.00%)
PYPL   78.53 (+0.15%)
PFE   51.08 (+1.90%)
NFLX   316.95 (+3.74%)
OTCMKTS:HKMPF

Hikma Pharmaceuticals - HKMPF Stock Forecast, Price & News

$18.23
0.00 (0.00%)
(As of 12/1/2022 12:00 AM ET)
Add
Compare
Today's Range
$18.23
$18.23
50-Day Range
$13.76
$18.23
52-Week Range
$13.76
$29.24
Volume
N/A
Average Volume
75 shs
Market Capitalization
$4.01 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
HKMPF stock logo

About Hikma Pharmaceuticals (OTCMKTS:HKMPF) Stock

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.

Receive HKMPF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

HKMPF Stock News Headlines

HKMPF Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC HKMPF Stock Chart
Hikma Pharma slides on lower generics guidance
Hikma Pharmaceuticals Plc 1H Rev $1.21B
Hikma Pharma CEO Siggi Olafsson Resigns - Quick Facts
Hikma Pharmaceutical FY EPS $1.807
Hikma Pharma FY21 Profit Down, Lifts Dividend; Stock Down
2 cheap UK stocks to buy for the rotation into value
Hikma Pharmaceuticals 1H Rev $1.22B
See More Headlines
Receive HKMPF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

HKMPF Company Calendar

Today
12/01/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Private households
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:HKMPF
CIK
N/A
Employees
8,700
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.55 billion
Cash Flow
$3.07 per share
Book Value
$10.18 per share

Miscellaneous

Free Float
N/A
Market Cap
$4.01 billion
Optionable
Not Optionable
Beta
0.52

Key Executives

  • Engineer Said Samih Taleb Darwazah (Age 65)
    Exec. Chairman & CEO
    Comp: $2.71M
  • Mr. Mazen Samih Taleb Darwazah (Age 64)
    Exec. Vice Chairman & Pres of MENA
    Comp: $2.11M
  • Mr. Khalid Waleed Hosny Al Nabilsi (Age 50)
    Chief Financial Officer
  • Mr. Hussein Arkhagha
    Company Sec. & Chief Counsel
  • Mr. Bassam Wael Rushdi Kanaan CFA (Age 57)
    CPA, Exec. VP of Corp. Devel. and M&A
  • Ms. Susan Ringdal
    Exec. VP of Strategic Planning & Global Affairs
  • Ms. Majda Labadi
    Exec. VP of Organisational Devel.
  • Mr. Riad Mishlawi
    Pres of Injectables
  • Mr. Brian Hoffmann
    Pres of Generics
  • Mr. Samuel Park
    Global Head of Intellectual Property (IP) & Gen. Counsel for US













HKMPF Stock - Frequently Asked Questions

Should I buy or sell Hikma Pharmaceuticals stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Hikma Pharmaceuticals in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" HKMPF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HKMPF, but not buy additional shares or sell existing shares.
View HKMPF analyst ratings
or view top-rated stocks.

How have HKMPF shares performed in 2022?

Hikma Pharmaceuticals' stock was trading at $28.64 at the start of the year. Since then, HKMPF shares have decreased by 36.3% and is now trading at $18.23.
View the best growth stocks for 2022 here
.

What is Hikma Pharmaceuticals' stock symbol?

Hikma Pharmaceuticals trades on the OTCMKTS under the ticker symbol "HKMPF."

How do I buy shares of Hikma Pharmaceuticals?

Shares of HKMPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Hikma Pharmaceuticals' stock price today?

One share of HKMPF stock can currently be purchased for approximately $18.23.

How much money does Hikma Pharmaceuticals make?

Hikma Pharmaceuticals (OTCMKTS:HKMPF) has a market capitalization of $4.01 billion and generates $2.55 billion in revenue each year.

How many employees does Hikma Pharmaceuticals have?

The company employs 8,700 workers across the globe.

How can I contact Hikma Pharmaceuticals?

Hikma Pharmaceuticals' mailing address is 1 NEW BURLINGTON PLACE, LONDON X0, W1S 2HR. The official website for the company is www.hikma.com. The company can be reached via phone at 442073992760, via email at investors@hikma.uk.com, or via fax at 44-20-7399-2761.

This page (OTCMKTS:HKMPF) was last updated on 12/1/2022 by MarketBeat.com Staff